Genmab — Februar 2018
-
2017 ser pænere ud end ventet, men jeg tror guidance for 2018 skuffer i høj grad - særligt indtjeningen (grundet øgede omkostninger) skuffer markant.
-
yup
-
Syntes det er en flot oversigtsside de har lavet på https://2017overview.genmab.com/
-
til Bulder
-
Selvom jeg naturligvis ser det som et meget konservativt bud, som de nok skal opjustere et par gange i løbet af året, tror jeg stadig at vi skal ned i morgen og i den kommende tid.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Det var måske sidste chance i det her niveau.